Anxiety, Mood, and Substance Use Disorders in Adult Men and Women with and Without Attention-Deficit/hyperactivity Disorder: A Substantive and Methodological Overview
Catharina A. Hartman,Henrik Larsson,Melissa Vos,Alessio Bellato,Berit Libutzki,Berit Skretting Solberg,Qi Chen,Ebba Du Rietz,Jeanette C. Mostert,Sarah Kittel-Schneider,Bru Cormand,Marta Ribases,Kari Klungsoyr,Jan Haavik,Soren Dalsgaard,Samuele Cortese,Stephen V. Faraone,Andreas Reif
DOI: https://doi.org/10.1016/j.neubiorev.2023.105209
2023-01-01
Abstract:Knowledge on psychiatric comorbidity in adult ADHD is essential for prevention, detection, and treatment of these conditions. This review (1) focuses on large studies (n > 10,000; surveys, claims data, population registries) to identify (a) overall, (b) sex-and (c) age-specific patterns of comorbidity of anxiety disorders (ADs), major depressive disorder (MDD), bipolar disorder (BD) and substance use disorders (SUDs) in adults with ADHD relative to adults without ADHD; and (2) describes methodological challenges relating to establishing comor-bidity in ADHD in adults as well as priorities for future research. Meta-analyses (ADHD: n = 550,748; no ADHD n = 14,546,814) yielded pooled odds ratios of 5.0(CI:3.29-7.46) for ADs, 4.5(CI:2.44-8.34) for MDD, 8.7 (CI:5.47-13.89) for BD and 4.6(CI:2.72-7.80) for SUDs, indicating strong differences in adults with compared to adults without ADHD. Moderation by sex was not found: high comorbidity held for both men and women with sex-specific patterns as in the general population: higher prevalences of ADs, MDD and BD in women and a higher prevalence of SUDs in men. Insufficient data on different phases of the adult lifespan prevented con-clusions on developmental changes in comorbidity. We discuss methodological challenges, knowledge gaps, and future research priorities.